.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Deloitte
Covington
Citi
Argus Health
Novartis
Chinese Patent Office
QuintilesIMS
Mallinckrodt

Generated: November 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: desmopressin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
7493III4/30/1988LONZA BRAINE SADESMOPRESSIN ACETATE
8044III4/26/1989IAF BIOCHEM INTERNATIONAL INCDESMOPRESSIN
8093III6/7/1989DIOSYNTH BVDESMOPRESSIN
8396AII1/26/1990POLYPEPTIDE LABORATORIES SWEDEN ABDESMOPRESSIN
9053III4/11/1991CARLBIOTECH LTD ASDESMOPRESSIN ACETATE
9386III10/24/1991MALLINCKRODT LLCDESMOPRESSIN
9951AII11/5/1992BACHEM AMERICAS INCDESMOPRESSIN ACETATE
10175AII3/30/1993ASPEN OSS BVDESMOPRESSIN
10283III6/10/1993BACHEM FEINCHEMIKALIEN AGDESMOPRESSIN ACETATE
14362III8/24/1999BACHEM INCDESMOPRESSIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
AstraZeneca
Teva
Argus Health
Queensland Health
UBS
McKinsey
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot